• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Kirk McDonald Appointed to Ziff Davis Board of Directors

    11/16/23 4:35:00 PM ET
    $ELAN
    $ZD
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Telecommunications Equipment
    Telecommunications
    Get the next $ELAN alert in real time by email

    Ziff Davis, Inc. (NASDAQ:ZD), today announced the appointment of Kirk McDonald to its Board of Directors, effective November 15, 2023. McDonald is a highly accomplished executive with extensive experience and a career spanning more than three decades in media, technology, and advertising.

    "We are thrilled to welcome Kirk to our Board of Directors," said Ziff Davis Board Chair Sarah Fay. "As an industry veteran known for his business leadership, he will be an asset to Ziff Davis."

    McDonald serves as CEO of GroupM North America, a leading media investment agency. He announced that he will leave the role at year end. Prior to this, he was Chief Business Officer of Warner Media's Xandr when it was a division of AT&T. He was also President of Pubmatic, and has held executive level leadership roles at Time Inc., the Aquantive division of Microsoft, and CNET Networks. McDonald currently serves on the board of Elanco (NYSE:ELAN), and is a founding member of the Black Executive CMO Alliance. He also serves on the boards of directors of industry organizations including the Ad Council (as co-chair), the Paley Center for Media, and the Advertising Week Advisory Council. An alumnus of the City College of New York, Mr. McDonald majored in English as an undergraduate.

    "Kirk is widely respected in our industry, and has been a leader and innovator across a range of companies in the media and advertising ecosystem," said Ziff Davis CEO Vivek Shah.

    "I am delighted to be joining the Ziff Davis Board of Directors," McDonald said. "I look forward to working with Vivek and the entire Ziff Davis team across its portfolio of leading brands."

    About Ziff Davis

    Ziff Davis (NASDAQ:ZD) is a vertically focused digital media and internet company whose portfolio includes leading brands in technology, shopping, gaming and entertainment, connectivity, health, cybersecurity, and martech. For more information, visit www.ziffdavis.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20231116449936/en/

    Get the next $ELAN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ELAN
    $ZD

    CompanyDatePrice TargetRatingAnalyst
    Elanco Animal Health Incorporated
    $ELAN
    10/7/2025$24.00Neutral → Overweight
    Analyst
    Elanco Animal Health Incorporated
    $ELAN
    7/17/2025$18.00Market Perform → Outperform
    Leerink Partners
    Elanco Animal Health Incorporated
    $ELAN
    6/26/2025Mkt Perform → Outperform
    William Blair
    Ziff Davis Inc.
    $ZD
    4/22/2025$33.00Overweight → Neutral
    Analyst
    Elanco Animal Health Incorporated
    $ELAN
    12/9/2024$18.00Buy
    UBS
    Elanco Animal Health Incorporated
    $ELAN
    12/2/2024$14.00Market Perform
    Leerink Partners
    Elanco Animal Health Incorporated
    $ELAN
    9/19/2024$17.00 → $15.00Overweight → Equal-Weight
    Morgan Stanley
    Ziff Davis Inc.
    $ZD
    5/2/2024$70.00Neutral → Overweight
    JP Morgan
    More analyst ratings

    $ELAN
    $ZD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Fay Sarah Ann bought $49,949 worth of Common Stock $0.01 Par Value (1,354 units at $36.89), increasing direct ownership by 6% to 23,619 units (SEC Form 4)

    4 - ZIFF DAVIS, INC. (0001084048) (Issuer)

    9/15/25 4:58:37 PM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    Director Kurzius Lawrence Erik bought $211,000 worth of shares (20,000 units at $10.55), increasing direct ownership by 22% to 111,459 units (SEC Form 4)

    4 - Elanco Animal Health Inc (0001739104) (Issuer)

    3/11/25 5:13:30 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Hoover R David bought $272,558 worth of shares (25,000 units at $10.90) (SEC Form 4)

    4 - Elanco Animal Health Inc (0001739104) (Issuer)

    3/7/25 4:21:21 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ELAN
    $ZD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Elanco Animal Health upgraded by Analyst with a new price target

    Analyst upgraded Elanco Animal Health from Neutral to Overweight and set a new price target of $24.00

    10/7/25 8:46:24 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Elanco Animal Health upgraded by Leerink Partners with a new price target

    Leerink Partners upgraded Elanco Animal Health from Market Perform to Outperform and set a new price target of $18.00

    7/17/25 7:51:30 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Elanco Animal Health upgraded by William Blair

    William Blair upgraded Elanco Animal Health from Mkt Perform to Outperform

    6/26/25 7:49:03 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ELAN
    $ZD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by PRESIDENT, CEO AND DIRECTOR Simmons Jeffrey N

    4 - Elanco Animal Health Inc (0001739104) (Issuer)

    10/21/25 4:21:52 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Officer Modi Rajeev A.

    4 - Elanco Animal Health Inc (0001739104) (Issuer)

    10/21/25 4:21:25 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Officer Modi Rajeev A.

    4 - Elanco Animal Health Inc (0001739104) (Issuer)

    10/7/25 4:47:22 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ELAN
    $ZD
    SEC Filings

    View All

    SEC Form 144 filed by Elanco Animal Health Incorporated

    144 - Elanco Animal Health Inc (0001739104) (Subject)

    8/11/25 3:58:15 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-Q filed by Ziff Davis Inc.

    10-Q - ZIFF DAVIS, INC. (0001084048) (Filer)

    8/7/25 4:18:26 PM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    SEC Form 10-Q filed by Elanco Animal Health Incorporated

    10-Q - Elanco Animal Health Inc (0001739104) (Filer)

    8/7/25 9:05:13 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ELAN
    $ZD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ziff Davis Appoints J.T. Farley Director of Investor Relations

    Ziff Davis, Inc. (NASDAQ:ZD), has appointed J.T. Farley Director of Investor Relations. In this role, Mr. Farley will lead engagement with the investment community and communicate the company's strategy, growth story, and financial performance. He will report to Bret Richter, Chief Financial Officer of Ziff Davis. Mr. Farley brings to Ziff Davis more than 15 years of experience in investor relations and strategic communications, primarily supporting public companies. He was Managing Director, Investor Relations at Cowen, where he led global investor relations. Mr. Farley also led investor relations and corporate communications for ITG and held sales and marketing roles at Bank of America

    10/20/25 4:01:00 PM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    Elanco to Host Investor Day on December 9

    INDIANAPOLIS, Oct. 16, 2025 /PRNewswire/ -- Elanco Animal Health, Inc. (NYSE:ELAN) will host an Investor Day on Tuesday, December 9, 2025, from approximately 9 a.m. to 12 p.m. Eastern Time in New York City. The event will feature presentations from Elanco's senior leadership team on the company's strategic priorities, financial outlook, and innovation pipeline – defining Elanco's new era of growth. Advance registration for the in-person event is required; institutional investors and analysts interested in attending should contact [email protected]. Registration and access fo

    10/16/25 4:32:00 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ziff Davis to Announce Third Quarter 2025 Earnings

    Ziff Davis, Inc. (NASDAQ:ZD) will release its Third Quarter 2025 Earnings at 6:00PM ET on Thursday, November 6, 2025. Additionally, Ziff Davis invites the public, members of the press, the financial community, stockholders, and other interested parties to listen to a live audio Webcast of its Third Quarter 2025 Earnings Call at 8:30AM ET on Friday, November 7, 2025. Vivek Shah, Chief Executive Officer, and Bret Richter, Chief Financial Officer, will host the call. Materials presented during the call will be posted on the Company's web site at ziffdavis.com and furnished as an exhibit to the Company's 8-K filed with the Securities and Exchange Commission pursuant to Regulation FD in connec

    10/16/25 7:00:00 AM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    $ELAN
    $ZD
    Financials

    Live finance-specific insights

    View All

    Elanco Confirms Date and Conference Call for Third Quarter 2025 Financial Results Announcement

    GREENFIELD, Ind., Oct. 1, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) will announce its third quarter 2025 financial results on Wednesday, November 5, 2025. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company's performance. The conference call will begin at 8:00 a.m. eastern time. Investors, media, and the general public can access a live webcast of the conference call through the link that will be posted on Elanco's website at https://investor.elanco.com/events-and-presentations/de

    10/1/25 8:00:00 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Elanco Animal Health Reports Second Quarter 2025 Results

    Raising Full Year Outlook and Innovation Target, Improving Year-End Net Leverage Ratio Target Second Quarter 2025 Financial Results:Revenue of $1,241 million, an increase of 5% year-over-year; 8% organic constant currency growthReported Net Income of $11 million, Adjusted Net Income of $131 millionAdjusted EBITDA of $238 million; Adjusted EBITDA Margin of 19.2% Reported EPS of $0.02, Adjusted EPS of $0.26Net leverage ratio of 4.0x Adjusted EBITDAFull Year 2025 Guidance:Raising revenue guidance to $4,570 to $4,620 million; expect accelerating organic constant currency revenue growth of 5% to 6% vs. 3% in 2024Raising 2025 innovation revenue target by $60 million to $720 to $800 millionReported

    8/7/25 6:27:00 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ziff Davis Reports Second Quarter 2025 Financial Results and Reaffirms 2025 Guidance

    Ziff Davis, Inc. (NASDAQ:ZD) ("Ziff Davis" or "the Company") today reported unaudited financial results for the second quarter ended June 30, 2025. "We are very pleased with our second quarter results, which exceeded expectations and marked our strongest quarterly revenue growth since 2021," said Vivek Shah, Chief Executive Officer of Ziff Davis. "Our new segment reporting is providing greater transparency into the intrinsic value of our key businesses, including breakthrough results from our Connectivity and Health & Wellness businesses." SECOND QUARTER 2025 RESULTS Q2 2025 quarterly revenues increased 9.8% to $352.2 million compared to $320.8 million for Q2 2024. Income from op

    8/6/25 6:00:00 PM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    $ELAN
    $ZD
    Leadership Updates

    Live Leadership Updates

    View All

    Ziff Davis Appoints J.T. Farley Director of Investor Relations

    Ziff Davis, Inc. (NASDAQ:ZD), has appointed J.T. Farley Director of Investor Relations. In this role, Mr. Farley will lead engagement with the investment community and communicate the company's strategy, growth story, and financial performance. He will report to Bret Richter, Chief Financial Officer of Ziff Davis. Mr. Farley brings to Ziff Davis more than 15 years of experience in investor relations and strategic communications, primarily supporting public companies. He was Managing Director, Investor Relations at Cowen, where he led global investor relations. Mr. Farley also led investor relations and corporate communications for ITG and held sales and marketing roles at Bank of America

    10/20/25 4:01:00 PM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    Ziff Davis to Announce Third Quarter 2025 Earnings

    Ziff Davis, Inc. (NASDAQ:ZD) will release its Third Quarter 2025 Earnings at 6:00PM ET on Thursday, November 6, 2025. Additionally, Ziff Davis invites the public, members of the press, the financial community, stockholders, and other interested parties to listen to a live audio Webcast of its Third Quarter 2025 Earnings Call at 8:30AM ET on Friday, November 7, 2025. Vivek Shah, Chief Executive Officer, and Bret Richter, Chief Financial Officer, will host the call. Materials presented during the call will be posted on the Company's web site at ziffdavis.com and furnished as an exhibit to the Company's 8-K filed with the Securities and Exchange Commission pursuant to Regulation FD in connec

    10/16/25 7:00:00 AM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    Elanco Animal Health Set to Join S&P MidCap 400; Sarepta Therapeutics to Join S&P SmallCap 600

    NEW YORK, Aug. 26, 2025 /PRNewswire/ -- Elanco Animal Health Inc. (NYSE:ELAN) will replace Sarepta Therapeutics Inc. (NASD: SRPT) in the S&P MidCap 400, and Sarepta Therapeutics will replace Brookline Bancorp Inc. (NASD: BRKL) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, September 2. S&P SmallCap 600 constituent Berkshire Hills Bancorp Inc. (NYSE:BHLB) is acquiring Brookline Bancorp in a deal expected to be completed soon, pending final closing conditions. Post merger, Berkshire Hills Bancorp will remain in the S&P SmallCap 600 with a name and ticker change to Beacon Financial Corp. (NYSE:BBT). Following is a summary of the changes that will take place prior

    8/26/25 6:15:00 PM ET
    $BHLB
    $BRKL
    $ELAN
    Banks
    Finance
    Savings Institutions
    Biotechnology: Pharmaceutical Preparations

    $ELAN
    $ZD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Ziff Davis Inc.

    SC 13G/A - ZIFF DAVIS, INC. (0001084048) (Subject)

    11/12/24 5:57:23 PM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    Amendment: SEC Form SC 13G/A filed by Ziff Davis Inc.

    SC 13G/A - ZIFF DAVIS, INC. (0001084048) (Subject)

    11/4/24 2:15:05 PM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    SEC Form SC 13G filed by Ziff Davis Inc.

    SC 13G - ZIFF DAVIS, INC. (0001084048) (Subject)

    10/31/24 11:55:01 AM ET
    $ZD
    Telecommunications Equipment
    Telecommunications